Logo of Huzzle

Graduate Intern, Cell Biology

image

Kite Pharma

Oct 7, 2023

Applications are closed

  • Internship
    Full-time
    Summer Internship
  • Science
  • San Francisco

Requirements

  • Basic Qualifications:
  • 18 years or older
  • Minimum GPA of 2.8
  • Eligible to work in the United States without work authorization sponsorship now or in the future
  • Currently enrolled in a full-time PhD program at an accredited U.S. based university/college
  • Must have completed at least one year of study at an accredited university/college prior to internship commencing
  • Enrolled full-time in the Fall Semester at an accredited U.S. based university/college after the completion of the internship – with earliest graduation date of December 2024 or Spring/Summer 2025
  • Able to complete a 10-12 consecutive week internship between May and August
  • Able to relocate if necessary and work at the designated site for the duration of the internship
  • Not be employed at the time the internship starts
  • Preferred Qualifications:
  • Currently enrolled in Graduate Degree with emphasis in immunology or cancer biology
  • Proficiency with MS Office Suite
  • Ability to identify issues and seek solutions
  • Ability to work both independently and collaboratively
  • Efficient, organized, and able to handle short timelines in a fast-paced environment
  • Experience and/or interest in the biotechnology, pharmaceutical or health-care industry
  • Tissue culture and sterile technique
  • Experience with multicolor flow-cytometry

Responsibilities

  • Design and execute experiments to evaluate CAR-T cell function
  • Manufacture CAR-T cells
  • CAR-T cell phenotyping
  • Perform in vitro cytotoxicity and proliferation assays
  • Evaluate cytokine secretion from coculture assays
  • Analyze, interpret and present data

At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer.

Science & Healthcare
Industry
1001-5000
Employees
2009
Founded Year

Mission & Purpose

Kite Pharma is a biopharmaceutical company specialising in the development and commercialisation of innovative cancer immunotherapies. Focused on creating groundbreaking treatments, Kite Pharma harnesses the power of living cells to engineer personalised therapies that combat various forms of cancer. Their ultimate goal is to revolutionise cancer treatment by providing effective and targeted therapies tailored to individual patients. With a commitment to advancing scientific discoveries and improving patient outcomes, Kite Pharma's purpose lies in pushing the boundaries of what's possible in the field of oncology through cutting-edge research and the development of transformative cell therapies.